Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

Alexander Edward Dela Cruz Drilon, Natasha Rekhtman, Maria E. Arcila et al. · The Lancet Oncology · 2016

Cited by 484 works. doi:10.1016/s1470-2045(16)30562-9

Authors

References